Pharmaceuticals Related News
Oak Hill Bio and Chiesi enrol first European patient in bronchopulmonary dysplasia treatment study
Oak Hill Bio and Chiesi Group have launched a groundbreaking study of a revolutionary bronchopulmonary dysplasia treatment for extremely premature infants.
Oak Hill Bio, a...
U701V ULT freezer: A welcome innovation for energy-efficient cold storage in life sciences
Ultra-low temperature (ULT) freezers play a critical role in life sciences, offering the necessary cold storage solutions for delicate biological materials that require strict...
How the medical cold chain defends vital supplies from natural disasters
The medical cold chain plays a vital role around the world in preserving the integrity of temperature-sensitive products, such as vaccines, medications, and biological...
Global collaboration announced to develop seralutinib for pulmonary hypertension
Chiesi Farmaceutici and Gossamer Bio Inc have entered into a global collaboration to develop seralutinib for pulmonary hypertension treatment.
Chiesi Group celebrates €3bn sales success in 2023
Chiesi Group, a renowned biopharmaceutical powerhouse headquartered in Parma, Italy, revealed €3bn in sales in 2023, a significant growth from the previous year.
With 31...
Digital trends that are revolutionising the medical cold chain
B Medical Systems explores the key innovations that are driving the digital transformation of the medical cold chain.
In the pharmaceutical world, the medical cold...
Vektor Pharma: leaders in thin film drug formulations
Vektor Pharma TF GmbH and its team have been leaders in the design, testing, and manufacture of thin film drug formulations.
Vektor Pharma TF GmbH ...
Correctly transporting pharmaceutical products and biospecimens to ensure patient safety and scientific accuracy
The transportation and storage of biospecimens and pharmaceuticals have become increasingly important in the healthcare industry.
These sensitive materials, ranging from tissue samples to life-saving...
How psychostimulants can damage dopamine production
Researchers from MedUni Vienna have identified the mechanisms behind the unwanted effects of psychostimulants, which are used to treat neuropsychiatric disorders.
Psychostimulants interact with dopamine...
EU regulation does not consider environmental emissions of pharmaceuticals
New research reveals that EU regulation is not currently considering the environmental emissions of pharmaceuticals in global manufacturing supply chains.
The EU regulation that covers...
Can ketamine help treat severe alcohol disorder?
A new trial from the University of Exeter will investigate whether ketamine-assisted therapy could help treat alcohol disorder.
The £2.4 million trial will be delivered...
Extracting medicinal mushrooms
As a result of the rising demand for therapeutic medications, medicinal mushrooms have become increasingly important in healthcare over the last ten years.
The rapid...
Blood thinning medication does not help COVID-19 recovery
Blood thinning medication does not help patients recovering from COVID-19, despite being offered to patients, according to research from the University of Cambridge.
Over 1,000...
Anti-cholesterol and diabetes drugs may reduce the risk of eye disease
Regularly taking anti-cholesterol and diabetes drugs may lessen the risk of degenerative eye disease associated with ageing, according to new research.
Findings from a pooled...
Bivalirudin is the safest treatment for percutaneous coronary intervention
Researchers have found that bivalirudin is a safer and more effective anticoagulant than heparin for treating percutaneous coronary intervention patients.
The researchers found that heart...
New Marfan syndrome treatment could delay the need for surgery
A new Marfan syndrome treatment could delay the need for surgery and reduce aortic root size in patients, according to research presented at the...
Big Boost for NervGen’s Phase II Clinical Trials
In a groundbreaking development for paralysed people, the revolutionary NVG-291 treatment for spinal cord injury is set to undergo Phase II clinical trials in...
NervGen: A new hope for treating spinal cord injuries
For decades, medical researchers have struggled in vain to solve the mystery of how to reverse paralysis caused by serious spinal cord injuries.
Finally, hope...
AccumTM variants successfully increase breast cancer treatment potency
Biotechnology experts Defence Therapeutics have revealed strong in vitro results of its AccumTM variants on the ADC breast cancer treatment called Enhertu® (fam-trastuzumab-deruxtecan-nxki), which...
Defence Therapeutics prepares to test its DC cancer vaccine against melanoma
Defence Therapeutics is finalising all required steps in preparation for a pre-IND meeting to initiate a phase I trial against melanoma using its DC cancer...